Treatment of Tularemia in Pregnancy
Tularemia occurring during pregnancy requires careful antibiotic selection. Pregnancy alters drug pharmacokinetics and restricts certain treatment options, making a targeted, evidence-based approach essential for both maternal and fetal safety.
Clinical Scenario
A pregnant patient with confirmed or suspected tularemia (any form). The presence of pregnancy directly shapes which antibiotics are appropriate, how they are dosed, and how different severities of presentation are managed.
Treatment Overview
First-line therapy draws on fluoroquinolones or an aminoglycoside, with selection and dosing calibrated to the physiological changes of pregnancy.
The complete regimen — including drug selection criteria, dosing considerations, management of severe disease, and route guidance — is detailed in the full protocol.
References
- For pregnant women with any form of tularemia, fluoroquinolones (i.e., ciprofloxacin or levofloxacin) or gentamicin are recommended for first-line treatment.
- The dose and duration of fluoroquinolones should align with recommendations for the nonpregnant adult population; however, more frequent administration of ciprofloxacin or levofloxacin might be required because of increased renal clearance of fluoroquinolones during the latter half of pregnancy.
View source ↗